TFS Capital’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-4,237
| Closed | -$178K | – | 205 |
|
|
2017
Q2 | $178K | Buy |
4,237
+3,363
| +385% | +$141K | 0.07% | 472 |
|
|
2017
Q1 | $49K | Sell |
874
-780
| -47% | -$43.7K | 0.02% | 626 |
|
|
2016
Q4 | $63K | Sell |
1,654
-408
| -20% | -$15.5K | 0.02% | 671 |
|
|
2016
Q3 | $82K | Buy |
2,062
+726
| +54% | +$28.9K | 0.02% | 679 |
|
|
2016
Q2 | $96K | Buy |
+1,336
| New | +$96K | 0.02% | 860 |
|
|
2015
Q3 | – | Sell |
-10,385
| Closed | -$4.32M | – | 982 |
|
|
2015
Q2 | $4.32M | Buy |
10,385
+8,350
| +410% | +$3.47M | 0.42% | 44 |
|
|
2015
Q1 | $967K | Buy |
+2,035
| New | +$967K | 0.09% | 357 |
|